Identification of the human liver microsomal cytochrome P450s involved in the metabolism of N-nitrosodi-n-propylamine

Carcinogenesis

Volumn 21, Issue 8, 2000, Pages 1559-1566

  Teiber, John F ^a,b   Hollenberg, Paul F ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2C9; CYTOCHROME P450 3A4; CYTOCHROME P450 ISOENZYME; DIETHYLDITHIOCARBAMIC ACID; DIPROPYLNITROSAMINE; MONOCLONAL ANTIBODY; TROLEANDOMYCIN;

ARTICLE; CHEMICAL CARCINOGENESIS; DENITRIFICATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER MICROSOME METABOLISM; PRIORITY JOURNAL;

EID: 0033859758     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.559     Document Type: Article

References (54)

1. Carcinogenesis in Fischer rats by nitrosodipropylamine, nitrosodibutylamine and nitrosobis(2-oxopropyl) amine given by gavage
2. Influence of ethyl alcohol on the carcinogenic activity of N-nitrosodi-n-propylamine
3. Carcinogenic nitroso compounds
4. Kinetics and enzymes involved in the metabolism of nitrosamines
5. Deuterium isotope effect on denitrosation and demethylation of N-nitrosodimethylamine by rat liver microsomes
6. Mechanisms of action of N-nitroso compounds
7. Alkylation of nucleic acids by N-nitrosodi-n-propylamine: Evidence that carbonium ions are not significantly involved
8. Comparative study of DNA damage and repair induced by ten N-nitroso compounds in primary cultures of human and rat hepatocytes
9. Metabolic nitrate formation from N-nitrosamines: Evidence for a cytochrome P-450 dependent reaction
10. The Fenton degradation as a nonenzymatic model for microsomal denitrosation of N-nitrosodimethylamine
11. Oxidative dealkylation and reductive denitrosation of nitrosomethylaniline in vitro
12. Metabolic denitrosation of N-nitrosamines: Mechanism and biological consequences
13. Metabolism of Nnitrosodialkylamines by human liver microsomes
14. Formation of hydroxy derivatives, aldehydes, and nitrite from N-nitrosomethyl-n-amylamine by rat liver microsomes and by purified cytochrome P-450
15. Identification of the cytochrome P450 isozymes involved in the metabolism of N-nitrosodipropyl-, Nnitrosodibutyl-and N-nitroso-n-butyl-n-propylamine
16. Role of cytochrome P450 in DNA damage reduced by N-nitrosodialkylamines in cultured rat hepatocytes
17. Alkylation of cellular macromolecules and target specificity of carcinogenic nitrosodialkylamines: Metabolic activation by cytochromes P450 2B1 and 2E1
18. Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes
19. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes
20. Measurement of protein using bicinchoninic acid
21. The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification and properties
22. A new assay for the microsomal metabolism of nitrosamines
23. Mechanism-based inactivation of cytochrome P450 3A4 by mifepristone (RU486)
24. Inactivation of cytochrome P450 2E1 by tert-butlyisothiocyanate
25. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by n-propylxanthate
26. Eight inhibitory monoclonal antibodies define the roll of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin, and imipramine metabolism
27. 1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines
28. Determination of cell number in monolayer cultures
29. The metabolism of nitrosodi-n-propylamine, nitrosodiallylamine and nitrosodiethanolamine
30. Cytochrome P450 inhibitors: Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes
31. Evaluation of the selectivity of in vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities
32. Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation
33. Human cytochrome P450 enzymes
34. Drug metabolism by Escherichia coli expressing human cytochromes P450
35. Escherichi, colt expression and substrate specificities of canine cytochrome P450 3A12 and rabbit cytochrome P450 3A6
36. Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli
37. Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coli
38. P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature
39. Oxidation of 1,3-butadiene to (R)- and (S) butadiene monoxide by purified recombinant cytochrome P450 2E1 from rabbit, rat and human
40. Nature of N-nitrosodimethylamine demethylase and its inhibitors
41. Production of DNA strand breaks by N-nitrosodimethylamine and 2-amino-3-methylimidazol4.5-flquinoline in THLE cells expressing human CYP isoenzymes and inhibition by sulforaphane
42. Possible mechanisms of Nnitrosodimethylamine hepatotoxicity
43. N-Alkylnitrosamines in domestic and imported cheese
44. Volatile nitrosamines in saltpreserved fish before and after cooking
45. National Institute for Occupational Safety and Health Health Hazard Evaluation, Report no. HETA 82-156-1231
46. Volatile N-nitrosamines in gastric juice of patients with various conditions of the gastrointestinal tract determined by gas chromatography-mass spectrometry and related to intragastric pH and nitrate and nitrite levels
47. Modulation of cytochrome P450 isozymes in human liver, by ethanol and drug intake
48. 3H-pentyl]methyln-amylnitrosamine by rat esophageal and liver microsomes and by rat and human cytochrome P450 isoforms
49. Comparative metabolism of the tobacco specific smoke carcinogens benzo[a]pyrene, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone,4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol, and N-nitrosonornicotine in human hepatic microsomes
50. Metabolism of nitrosamines in vivo
51. Microsomal metabolism of N-nitrosodin-propylamine: Formation of products resulting from α- and β-oxidation